Articles On Telix Pharmaceuticals (ASX:TLX)

ASX ends very modestly lower after a mixed session Newmont and Fortescue shares drop on disappointing updates WiseTech continues its slide as investors start to grumble   Aussie shares swung to a flattish close today after earlier losses...

The S&P/ASX 200 Index (ASX: XJO) is fighting hard to stay in positive territory. In afternoon trade, the benchmark index is up 0.1% to 8,223.7 points. Four ASX shares that are rising more than most today are listed below. Here's why t...

Telix Pharmaceuticals’ brain cancer diagnostic could leapfrog over its kidney cancer assay to be its second commercialised product Rhythm Biosciences still hopes to flush the bowel cancer ‘poo test’ into history Today’s quarterly reports s...

Telix Pharmaceuticals Ltd (ASX: TLX) shares are rising on Thursday morning. In morning trade, the ASX 200 healthcare stock is up 2% to $21.54 Why is this ASX 200 healthcare stock rising? Investors have been bidding the radiopharmac...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia, Oct. 24, 2024 /PRNewswire/ — Telix Pharmaceuticals Limited...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia, Oct. 22, 2024 /PRNewswire/ — Telix Pharmaceuticals Limited...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin An additional news report on the recommendation, valuation, forecast and opinion cha...

Not every S&P/ASX 200 Index (ASX: XJO) stock is going to shoot the lights out and deliver 10-bagger plus returns in just five years. Indeed, some will invariably head in the other direction and erode the value of your initial invest...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin SPI futures on the S&P/ASX 200 are up 0.5%, inching the benchmark back up toward...

The S&P/ASX 200 Index (ASX: XJO) endured a fairly miserable end to the trading week this Friday, with investors pulling back from the new record highs we saw yesterday. By the time trading wra...

Highlights ASX falls as weak Chinese economic data hits commodity stocks. Gold miners rally while most sectors experience losses. Major banks post mixed results amidst broader market decline. Australian stocks extended their losse...

A top ASX stock is heading off to try its fortunes on the Nasdaq Composite Index (NASDAQ: .IXIC). Don't worry, though. If its Nasdaq listing plans proceed as planned, the S&P/ASX 100 Index (ASX: XTO) company will be dual-listed, me...

Telix Pharmaceuticals (ASX:TLX) reveals its quarterly revenues while also reaffirming its full-year 2024 revenue guidance. In a statement, the company said that for the quarter revenue totaled AU$201, primarily generated from sales of i...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia, Oct. 17, 2024 /PRNewswire/ – Telix Pharmaceuticals Limited...

  ASX closes  higher led by Wall Street gains ReNu Energy reveals partial offer for hydrogen assets Web Travel plunges 30pc amid declining margins   The ASX closed 0.47% higher on Monday, buoyed by strong Wall Street leads, with the S&am...

Cancer drug developer Chimeric Therapeutics eyes minimum $5 million raising ‘The next Telix’, Clarity gets FDA go-ahead for prostate cancer trial LTR Pharma fleshes out erectile dysfunction trial results   Cancer cell therapy house Chimer...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia, Oct. 8, 2024 /PRNewswire/ — Telix Pharmaceuticals Limited (...

Big biotech names support Island Therapeutics raising Radiopharm eyes FDA approval to start a therapeutic pan-cancer trial Truscreen’s cervical cancer diagnostic cracks a nice mention   Health Check is renowned biotech journo Tim Boreham’...

Biome Australia believes it can almost quadruple its probiotics revenue over next three years  Anteris faces delay to proposed Nasdaq listing and IPO Artrya asks FDA to approve its AI-based heart plaque detection algo Stalemate: Pacific Sm...

The S&P/ASX 200 Index (ASX: XJO) has been on form this year and has recorded a solid gain. Since the start of the year, the benchmark index has risen 8.2%. And this doesn't include the dividends that have been paid during the period....

“Your Stock Request” is a weekly video where we analyse share price charts for stocks on the Australian market (ASX) as requested by you! Email us at [email protected] with your stock request. Limit of one per person, no guarantee o...

ASX healthcare sector shows signs of recovery after latest earnings season Pathology and aged care face ongoing staffing and cost challenges Jarden highlights Telix Pharma and CSL as key investment picks   Key themes of FY24 reporting sea...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin World Overnight SPI Overnight 8196.00 – 9.00 – 0.11% S&P ASX 200 8152.90 –...

The Australian sharemarket experienced a decline from record highs, primarily due to investor concerns regarding the Reserve Bank's potential delay in interest rate cuts, expected to remain steady at 4.35 per cent for the seventh consecutiv...

Melbourne-based biotech Telix Pharmaceuticals (ASX: TLX) has expanded its North American manufacturing base through the acquisition of RLS (USA) Inc for up to US$250 million ($366.5 million). The deal gives Telix access to 31 licensed radi...

Telix Pharmaceuticals Limited (ASX: TLX), a prominent oncology company specializing in radiopharmaceuticals, has announced its acquisition of RLS (USA), Inc. for $338 million (USD 230 million). This strategic move significantly expands Teli...

Telix Pharmaceuticals Ltd (ASX: TLX) shares are falling on Monday morning. At the time of writing, the ASX 200 healthcare stock is down 3.5% to $19.57 Why is this ASX 200 healthcare stock falling? Investors have been selling the company's s...

The ASX 200 is forecasted to experience a downturn, with futures down 0.8% to 8190 points, following last week's record highs. A range of important economic events and corporate updates are expected to influence market movements.   The Aus...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia, INDIANAPOLIS and LAKE MARY, Fla., Sept. 23, 2024 /PRNewswi...

Melbourne-based Telix Pharmaceuticals Ltd (ASX:TLX) is set to expand its manufacturing and distribution footprint in North America with the acquisition of RLS Inc – the only US radiopharmacy network which is Joint Commission-accredited....

The S&P/ASX 200 Index (ASX: XJO) ended the trading week on a high this Friday. Literally so, with the index once again resetting its intraday trading re...

Aus shares have reached a record high, while Myer highlights challenging market conditions. Regis Healthcare and Kelsian have secured significant contracts, and Namoi Cotton has endorsed Olam Agri's acquisition bid. The Australian dollar ha...

It was a bouncy but overall positive day for the S&P/ASX 200 Index (ASX: XJO) this Thursday. By the time trading closed, the ASX 200 had climbed by ano...

It ended up being quite a wonderful day for the S&P/ASX 200 Index (ASX: XJO) this Tuesday. The ASX 200 managed to add 0.24% to its value and closed up at 8...

At 11:40am, the S&P/ASX 200 is 0.23 per cent higher at 8,140.50. This comes amid expectations of a significant 50 basis point interest rate cut by the Federal Reserve later this week, with JPMorgan predicting the move and CME Futures da...

The Australian sharemarket briefly touched a new record high on Monday, mirroring a surge in US stocks. Banks and gold stocks led the gains, while energy and health sectors lagged.At the closing bell, the S&P/ASX 200 was 0.27 per cent h...

At 11:35am, the S&P/ASX 200 is 0.37 per cent higher at 8,130.20, buoyed by a rally on Wall Street driven by gains in tech and gold stocks. US stocks surged on Friday amid expectations that the US Federal Reserve will lower interest rate...

Alive and Kicking is renowned biotech journo Tim Boreham’s new daily wrap covering morning movers and shakers of note in the ASX Healthcare sector, Monday through Thursday.   Prescient Therapeutics chief Steve Yatomi-Clarke resigns to hea...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia, Sept. 11, 2024 /PRNewswire/ — Telix Pharmaceuticals Limited...

Investors are keeping a close eye on several S&P/ASX 200 Index (ASX: XJO) shares, with two particular stocks standing out for their potential to outperform. These two companies represent different sectors—one in mining and the other in...

Below, we look at two compelling S&P/ASX 200 Index (ASX: XJO) shares you may wish to consider adding to your portfolio. One stock has been under intense selling pressure in 2024 while the other has seen its share price rocket. And David...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Welcome to the FNArena Corporate Results Monitor. Today’s Reports: ((AIS)) – Aeris...

Australian shares opened higher, buoyed by a rise in tech stocks, particularly Tesla and Amazon, which lifted the Nasdaq amid mixed performance on Wall Street. At 11:35am, the S&P/ASX 200 is 0.17 per cent higher at 7,995.60, with four o...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia, Sept. 4, 2024 /PRNewswire/ — Telix Pharmaceuticals Limited...

Noxopharm says two novel drug candidates significantly reduced glioblastoma (brain cancer) cell growth in preclinical models. Percheron Therapeutics announces “very encouraging” new data for its epilepsy program Cyclopharm is off to a soli...

In the first session of the week, the Australian sharemarket is experiencing a decline, primarily driven by weakness in mining and communications stocks. By midday, the S&P/ASX 200 index is down 0.3 per cent, hovering near 8067 points....

Telix Pharmaceuticals (ASX:TLX) CEO and co-founder Dr Chris Behrenbruch is blunt about why some fund managers believe the ASX market darling is entering ‘overvalued’ territory. “The fundies probably hate [us] because they didn’t get their a...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Looks like the local market is set for yet again a weaker opening on Thursday. Wor...

The Australian share market closed flat on Wednesday, with consumer staples offsetting losses in commodity stocks. Woolworths' strong earnings boosted the consumer staples sector, while lower iron ore and uranium prices weighed on mining an...

Telix Pharmaceuticals (ASX:TLX) has announced its receipt of fast track status from the US FDA within the approvals chain for the assessment of Telix’s PET-scan brain cancer imaging agent Pixclara. The company is focusing particularly on...